logo BDSP

Base documentaire

  1. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment.

    Article, Communication - En anglais

    Society of Behavioral Medicine Conference - International cancer congress (VICC). Boston MA USA ; New Dehli IND, 1994/04/16 - 1994/11/04.


    Using an a priori theoretic model of behavior change, factors predicting enrollment in a randomized chemoprevention trial during the first year of recruitment were assessed prospectively.


    Eligible participants were asked to complete a 90-item semistructured questionnaire after attendance at an informational meeting.

    Components of the Health Belief Model (including perceived susceptibility, perceived severity, perceived benefits and barriers, cues to action, and health motivation), health status, preventive health behaviors, and social influence were assessed in relation to enrollment.


    Overall, 331 women attended one of the meetings, and 73% completed a questionnaire ; 45% enrolled on the trial and 55% did not.

    In bivariate analyses, all but one of the perceived barriers were associated negatively with enrollment ; however, items assessing perceived susceptibility, perceived severity, and perceived benefits were not.


    These findings support the view that recruitment efforts for chemoprevention trials should address barriers specific to their circumstances.

    In addition, increasing the support available from personal social networks may enhance recruitment to chemoprevention trials for breast cancer.

    Cancer 1995 ; 76 : 46-56.

    Mots-clés Pascal : Tumeur maligne, Glande mammaire, Prévention, Programme sanitaire, Tamoxifène, Anticancéreux, Participation, Homme, Femelle, Antioestrogène, Glande mammaire pathologie, Composé non stéroïde, Chimioprophylaxie, Facteur prédictif

    Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Prevention, Sanitary program, Tamoxifene, Antineoplastic agent, Participation, Human, Female, Antiestrogen, Mammary gland diseases, Chemoprophylaxis, Predictive factor

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0473624

    Code Inist : 002B02R02. Création : 01/03/1996.